A new way for consumers to know their skin
When it comes to the risk for developing nonmelanoma skin cancer, what’s visible on the surface is not the whole story. With Luminate™, it’s possible to know more, even before damage is visible on the skin’s surface.
The Luminate Skin Cancer DNA Risk Assessment is a first of its kind, at-home collection, noninvasive skin test that looks for UV-induced DNA damage in nonlesional skin cells, which may increase the risk of developing the most common types of skin cancer. So consumers can be proactive about their skin health.
Sign up for more updates about Luminate, coming later this year.